Literature DB >> 12690640

Effects of vinconate on scopolamine-induced memory impairment in rhesus monkeys.

Kiyoshi Ando1, Naoyuki Hironaka, Katsuro Shuto.   

Abstract

Effects of vinconate on specifically impaired short-term memory were studied in rhesus monkeys. Monkeys were trained to perform for orange juice reinforcement under a matching-to-sample response procedure. In the procedure, monkeys had to choose one of two stimuli that had the same color as the sample stimulus. Half of a daily session consisted of simultaneous trials where the sample stimulus was present during the time of choice. The other half of the session consisted of delayed trials where the sample stimulus had been presented but withheld at the time of choice. After the repeated training, the matching-to-sample responses were established with the percentage of correct choice responses (CR%) in both types of trials exceeding 90%. The doses of scopolamine, intervals between administration of this drug and the start of test session, and delay times in delayed trials were adjusted from one monkey to another so that delayed matching-to-sample responses were impaired by scopolamine while simultaneous matching-to-sample responses were less impaired by this drug. Scopolamine (32 or 45 micrograms/kg, s.c.) decreased the CR% for delayed trials more markedly than the CR% for simultaneous trials in four monkeys. Intragastrically administered vinconate at 16 mg/kg attenuated the scopolamine-induced short-term memory impairment. These results suggested that vinconate possesses specific ameliorating action on memory impairment caused by hypofunction of the cholinergic system in the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690640

Source DB:  PubMed          Journal:  Nihon Shinkei Seishin Yakurigaku Zasshi        ISSN: 1340-2544


  1 in total

1.  Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious preclinical evaluations.

Authors:  Kiyoshi Ando; Takashi Inoue; Keigo Hikishima; Yuji Komaki; Kenji Kawai; Ryo Inoue; Chiyoko Nishime; Eiko Nishinaka; Koji Urano; Hideyuki Okano
Journal:  Behav Pharmacol       Date:  2020-02       Impact factor: 2.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.